Healthcare - Biotechnology - NASDAQ - US
$ 34.45
-1.71 %
$ 9.84 B
Market Cap
22.23
P/E
Price Target
Average
--11.54%
Revenue Forecast
Estimate
13.98%
EBIT
Estimate
33.77%
Net Income
Estimate
48.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exelixis, Inc.
Wall Street analysts predict an average 1-year price target for EXEL of $30.5 , with forecasts ranging from a low of $18 to a high of $38 .
EXEL Lowest Price Target
Wall Street Target
18 USD
-47.75%
EXEL Average Price Target
Wall Street Target
30.5 USD
-11.54%
EXEL Highest Price Target
Wall Street Target
38 USD
10.30%
REVENUE FORECAST
Revenue Forecast Chart EXEL
EBIT FORECAST
EBIT Forecast Chart EXEL
NET INCOME FORECAST
Net Income Chart EXEL